• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. ARMADA; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. ARMADA; PERIPHERAL DILATATION CATHETER Back to Search Results
Model Number A2025-200
Medical Device Problem Codes Deflation Problem (1149); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/11/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.H6: device code 2017- contrast incorrect.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion in the tibioperoneal trunk with calcification.The 2.5x200 mm armada percutaneous transluminal angioplasty (pta) catheter did not fully deflate after use.The contrast mix was 1/3 saline, 1/3 contrast and the balloon was inflated to nominal pressure.The device was withdrawn inflated.There were no adverse patient effects and there was no clinically significant delay in the procedure.No additional information was provided.
 
Event or Problem Description
Subsequent to the initially filed report it was reported the contrast ratio was 1/3 contrast to 2/3 saline.The balloon was inflated once and negative pressure was held for 15 seconds.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.It was reported that the contrast mix used in the procedure was 1/3 contrast to 2/3 saline.It should be noted that the pta catheter, armada 14, global, instructions for use ifu, specified that the contrast is 60% contrast diluted 1:1 with normal saline.In this case, since 1/3 contrast to 2/3 saline ration was used and is less contrast concentration than the required percentage, it is unknown if the ifu violation caused or contributed to the reported complaint.Based on the information provided, a definitive cause for the reported deflation issue could not be determined.Possible factors that may contribute to difficulty deflating the balloon include, but are not limited to, deflation technique, tortuous anatomy, loose connection with the indeflator, contamination in the inflation lumen or damage to the guide wire and/or inflation lumen.A conclusive cause for the reported deflation issue could not be determined since the device was not returned for analysis.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.B5 - describe event or problem: updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA
Common Device Name
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key21057007
Report Number2024168-2025-00027
Device Sequence Number18306802
Product Code DQY
UDI-Device Identifier08717648156052
UDI-Public(01)08717648156052(17)270531(10)3122041
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K102705
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberA2025-200
Device Catalogue NumberA2025-200
Device Lot Number3122041
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/12/2024
Supplement Date Received by Manufacturer01/15/2025
Initial Report FDA Received Date01/02/2025
Supplement Report FDA Received Date01/17/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured12/20/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-